The comparative analysis of transradial and transfemoral vascular approaches for chemoembolization of pancreatic cancer
- 作者: Khayrutdinov E.1, Gromov D.1,2, Arablinskiy A.3
-
隶属关系:
- Pirogov Russian National Research Medical University (Pirogov Medical University)
- State Clinical Hospital named after F.I. Inozemtsev
- State Clinical Hospital named after S.P. Botkin
- 期: 卷 26, 编号 5 (2021)
- 页面: 155-162
- 栏目: Original Study Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/109224
- DOI: https://doi.org/10.17816/onco109224
- ID: 109224
如何引用文章
详细
BACKGROUND: Pancreatic cancer is one of the most aggressive malignant neoplasms, and the results of treatment of which remain extremely unsatisfactory. One of the methods to increase the effectiveness of surgical treatment of pancreatic cancer is selective oil chemoembolization of the pancreatic arteries. Transfemoral access is typically used as a vascular access during this type of intervention, in which complications from the vascular access are often observed.
AIM: This study aimed to analyze the results of the use of transradial and transfemoral approaches for chemoembolization of pancreatic cancer.
MATERIALS AND METHODS: We analyzed the results of chemoembolization of pancreatic arteries in 32 patients with pancreatic cancer. Transfemoral access was used in 16 (50%) patients and transradial access in 16 (50%) patients. According to the main clinical and anamnestic data, both groups were comparable. The endpoints of the study were technical success and complication rate of chemoembolization, total duration of the procedure, time needed for catheterization of the target artery, radiation exposure, and degree of discomfort for the patient.
RESULTS: Chemoembolization of pancreatic arteries was successfully performed in 100% of patients in both groups. Major vascular complications were observed in three (18.8%) patients in the transfemoral access group and in one (6.3%) in the transradial access group (p=0.6). The total duration of the procedure and the time needed for catheterization of the target artery were 54.54±6.61 and 51.30±6.46 min (p=0.17) and 12.7 and 13.25 min (p=0.72), respectively. Radiation exposure was 0.68±0.10 mSv in the transfemoral access group and 0.65±0.10 mSv in the transradial access group (р=0.4). Transradial access was associated with a statistically significant reduction in all parameters of procedural discomfort.
CONCLUSION: In terms of efficiency and safety of use, the transradial approach is not inferior to the traditional transfemoral approach, and in terms of patient comfort, it can be recommended as a priority for chemoembolization of the pancreatic arteries.
作者简介
Evgeny Khayrutdinov
Pirogov Russian National Research Medical University (Pirogov Medical University)
编辑信件的主要联系方式.
Email: eugkh@yandex.ru
ORCID iD: 0000-0003-1638-6385
SPIN 代码: 2438-5311
Cand. Sci. (Med.)
俄罗斯联邦, MoscowDmitriy Gromov
Pirogov Russian National Research Medical University (Pirogov Medical University); State Clinical Hospital named after F.I. Inozemtsev
Email: gromovdg@list.ru
ORCID iD: 0000-0001-7500-4987
SPIN 代码: 3940-4190
Dr. Sci. (Med.)
俄罗斯联邦, Moscow; MoscowAlexander Arablinskiy
State Clinical Hospital named after S.P. Botkin
Email: alexar-card@mail.ru
ORCID iD: 0000-0002-2117-5016
SPIN 代码: 5221-4250
Dr. Sci. (Med.)
俄罗斯联邦, Moscow参考
- Kubyshkin VA, Vishnevskij VA. Rak podzheludochnoj zhelezy. Moscow: Medpraktika; 2003. 375 p. (In Russ).
- Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221(1):59–66. doi: 10.1097/00000658-199501000-00007
- Ishikawa O, Ohigashi H, Imaoka S, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple’s procedure for adenocarcinoma of the pancreatic head? Arch Surg. 1994;129(10):1075–1080. doi: 10.1001/archsurg.1994.01420340089017
- Kozlov AV, Tarazov PG, Pavlovskiy AV, et al. Arterial chemoembolization in patients with locally advanced pancreatic cancer. Grekov’s Bulletin of Surgery. 2018;177(1):31–36. doi: 10.24884/0042-4625-2018-177-1-31-36 (In Russ).
- Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65(2):196–202. doi: 10.1002/ccd.20354
- Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409–1420. doi: 10.1016/S0140-6736(11)60404-2
- Chu HH, Kim JW, Shin JH, Cho SB. Update on transradial access for percutaneous transcatheter visceral artery embolization. Korean J Radiol. 2021;22(1):72–85. doi: 10.3348/kjr.2020.0209
- Khayrutdinov ER, Vorontsov IM, Zharikov SB, et al. The advantage of the transradial approach for prostate artery embolization. Russian Journal of Oncology. 2017;22(2):84–88. doi: 10.18821/1028-9984-2017-22-2-84-88 (In Russ).
- Khayrutdinov ER, Arablinskiy AV. The advantages of transradial vascular access in epistaxis embolization. Russian Otorhinolaryngology. 2017;(1):98–104. (In Russ).
- Khayrutdinov ER, Tsurkan VA, Arablinskiy AV, Gromov DG. The first experience of radial artery approach for selective chemoembolization of pancreatic cancer. Diagnostic and Interventional Radiology. 2017;11(4):81–85. (In Russ).
- Shiozawa S, Tsuchiya A, Endo S, et al. Transradial approach for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: comparison with conventional transfemoral approach. J Clin Gastroenterol. 2003;37(5):412–417. doi: 10.1097/00004836-200311000-00013
- Loewenstern J, Welch C, Lekperic S, et al. Patient radiation exposure in transradial versus transfemoral yttrium-90 radioembolization: a retrospective propensity score-matched analysis. J Vasc Interv Radiol. 2018;29(7):936–942. doi: 10.1016/j.jvir.2018.02.011
- Wu T, Sun R, Huang Y, et al. Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma. Indian J Cancer. 2015;52(Suppl 2):107–111. doi: 10.4103/0019-509X.172505